Ketrel

Tretinoin, the active ingredient in Ketrel, is a retinoid presented as a topical formulation for skin application. It is used to treat acne vulgaris, photodamage and other hyperkeratinizing skin disorders by promoting cellular differentiation and reducing inflammation in affected areas.

GNH USA supplies Ketrel as a licensed, GDP‑compliant international pharmaceutical product, providing reliable bulk and unit‑dose shipments to hospitals, pharmacies, dermatology clinics and procurement teams across global markets, with full regulatory documentation and support. This includes temperature‑controlled logistics where required to maintain product integrity.

Tretinoin is a topical retinoid that modulates skin cell growth and inflammation, making it useful for several dermatological conditions. - Acne vulgaris: Reduces comedones and inflammatory lesions by normalizing follicular keratinization. - Photodamage (skin aging): Improves fine lines, hyperpigmentation and texture by stimulating collagen synthesis and epidermal turnover. - Hyperkeratinizing disorders (e.g., psoriasis, ichthyosis): Softens plaques and reduces scaling through regulation of keratinocyte differentiation.

Topical tretinoin can cause a range of skin reactions, most of which are mild and reversible, while rare events may require medical attention.

Common Side Effects: - Irritation: Redness, burning or stinging at the application site. - Dryness and peeling: Flaking of the treated skin. - Increased photosensitivity: Greater susceptibility to sunburn.

Serious or Rare Side Effects: - Severe dermatitis: Widespread or intense skin inflammation. - Allergic contact dermatitis: Hives, swelling or rash beyond the treated area. - Ocular irritation: Eye redness or irritation if product contacts eyes.

When using Ketrel, several precautions should be observed to minimize adverse reactions and ensure safe handling. - Application frequency: Follow prescriber instructions, typically once daily in the evening. - Sun protection: Use broad‑spectrum sunscreen and protective clothing during daylight. - Avoid concurrent irritants: Do not combine with other topical acne agents such as benzoyl peroxide unless directed. - Pregnancy contraindication: Do not use during pregnancy (Category X) due to teratogenic risk. - Discontinue if severe reaction: Stop treatment and seek medical advice if serious dermatitis develops. - Store at room temperature: Keep below 25 °C in the original container, protected from moisture and light.

Topical tretinoin may interact with other topical or systemic agents, affecting efficacy or tolerability.

Major Interactions (Avoid): - Concurrent use with strong irritants (e.g., high‑strength benzoyl peroxide) that can cause severe skin irritation. - Systemic retinoids (e.g., isotretinoin) due to additive teratogenic risk.

Moderate Interactions (Monitor Closely): - Use with other photosensitizing drugs (e.g., tetracyclines) may increase sun sensitivity. - Combination with corticosteroid creams may reduce irritation but requires monitoring for steroid overuse. - Concurrent use of chemical peels or laser therapy may enhance irritation; schedule appropriately.